8102
-
OncoTargets and Therapy
Open access peer-reviewed scientific and medical journals.
Dove Medical Press is now a member of the Open Access Initiative
A guide to help authors get their paper published.
Support Open Access and Dove Press
Promotional Article Monitoring - further details
Real benefits for authors, including fast-track processing of papers.
OncoTargets and Therapy
(347,932) Views
Editor in Chief Professor Hans-Joachim Schmoll
1178-6930
ReviewBendamustine in the treatment of non-Hodgkin’s lymphomas
Fredrick Hagemeister, George Manoukian
OncoTargets and Therapy 2009, 2:269-279
04 December 2009
Review
Safety and efficacy of sorafenib in the treatment of hepatocellular carcinoma
Khaldoun Almhanna, Philip A Philip
OncoTargets and Therapy 2009, 2:261-267
13 November 2009
Review
Rational use of cetuximab in the treatment of advanced non-small cell lung cancer
Charu Aggarwal, Hossein Borghaei
OncoTargets and Therapy 2009, 2:251-260
31 August 2009
Review
Recent results of cetuximab use in the treatment of squamous cell carcinoma of the head and neck
Francesco Perri, Francesco Longo, Franco Ionna, et al
OncoTargets and Therapy 2009, 2:243-250
31 August 2009
Review
Update on the rational use of tositumomab and iodine-131 tositumomab radioimmunotherapy for the treatment of non-Hodgkin’s lymphoma
Michael J Burdick, Roger M Macklis
OncoTargets and Therapy 2009, 2:229-242
19 August 2009
Review
Profile of nelarabine: use in the treatment of T-cell acute lymphoblastic leukemia
Kelly M Reilly, David F Kisor
OncoTargets and Therapy 2009, 2:219-228
06 August 2009
Review
Gemcitabine for the treatment of advanced nonsmall cell lung cancer
Luca Toschi, Federico Cappuzzo
OncoTargets and Therapy 2009, 2:209-217
03 August 2009
Review
Update on the rational use of (90)Y-ibritumomab tiuxetan in the treatment of follicular lymphoma
Martina Lehnert, Heinz Ludwig, Niklas Zojer
OncoTargets and Therapy 2009, 2:199-208
31 July 2009
Review
Expanded use of rituximab in the management of non-Hodgkin lymphoma
Dennis A Eichenauer, Andreas Engert, Holger Schulz
OncoTargets and Therapy 2009, 2:189-197
31 July 2009
Review
Targeted delivery of albumin bound paclitaxel in the treatment of advanced breast cancer
Francesco Di Costanzo, Silvia Gasperoni, Virginia Rotella, Federica Di Costanzo
OncoTargets and Therapy 2009, 2:179-188
07 July 2009
Review
The ubiquitin–proteasome system as a molecular target in solid tumors: an update on bortezomib
A Milano, F Perri, F Caponigro
OncoTargets and Therapy 2009, 2:171-178
30 June 2009
Review
Targeting colorectal cancer with anti-epidermal growth factor receptor antibodies: focus on panitumumab
Kerry J Williams, A Craig Lockhart
OncoTargets and Therapy 2009, 2:161-170
30 June 2009
Review
Role of imatinib in the management of early, operable, and advanced GI stromal tumors (GISTs)
John T Vetto
OncoTargets and Therapy 2009, 2:151-159
25 June 2009
Review
Multiple roles and therapeutic implications of Akt signaling in cancer
Emiliano Calvo, Victoria Bolós, Enrique Grande
OncoTargets and Therapy 2009, 2:135-150
05 June 2009
Review
Targeted therapy in the treatment of malignant gliomas
Rimas V Lukas, Adrienne Boire, M Kelly Nicholas
OncoTargets and Therapy 2009, 2:115-133
13 May 2009
Review
Role of trabectedin in the treatment of soft tissue sarcoma
Alexandre Christinat, Serge Leyvraz
OncoTargets and Therapy 2009, 2:105-113
06 May 2009
Review
The evolving role of zoledronic acid in early breast cancer
Michael Gnant
OncoTargets and Therapy 2009, 2:95-104
26 April 2009
Review
Targeted treatment of imatinib-resistant chronic myeloid leukemia: Focus on dasatinib
Charles Chuah, Junia V Melo
OncoTargets and Therapy 2009, 2:83-94
24 April 2009
Review
First-line targeted therapies in the treatment of metastatic colorectal cancer – role of cetuximab
Giuseppe Tonini, Alice Calvieri, Bruno Vincenzi, Daniele Santini
OncoTargets and Therapy 2009, 2:73-82
07 April 2009
Review
Targeted treatment of chronic myeloid leukemia: role of imatinib
Ila Tamascar, Jeyanthi Ramanarayanan
OncoTargets and Therapy 2009, 2:63-71
25 March 2009
Review
Management of side effects associated with sunitinib therapy for patients with renal cell carcinoma
Anita Schwandt1, Laura S Wood1, Brian Rini1,2, Robert Dreicer1,2
OncoTargets and Therapy 2009, 2:51-61
16 March 2009
Review
Role of bendamustine in the treatment of chronic lymphocytic leukemia
Saad Jamshed, Bruce D Cheson
OncoTargets and Therapy 2009, 2:43-49
12 March 2009
Review
Targeting cancers in the gastrointestinal tract: role of capecitabine
Muhammad Wasif Saif
OncoTargets and Therapy 2009, 2:29-41
25 March 2009
Review
Current status of treatment of metastatic colorectal cancer with special reference to cetuximab and elderly patients
Per Pfeiffer, Camilla Qvortrup, Jon K Bjerregaard
OncoTargets and Therapy 2009, 2:17-27
23 December 2008
Review
Targeted therapies in the management of colorectal carcinoma: role of bevacizumab
Ajithkumar Puthillath, Anush Patel, Marwan G Fakih
OncoTargets and Therapy 2009, 2:1-15
27 November 2008
- Have an opinion about one of our articles?
We encourage you to write a Letter to the Editor
- Testimonials
"... I was impressed at the rapidity of publication from submission to final acceptance." Dr Edwin Thrower, PhD, Yale University
- Intranet access to all Dove journals
If you would like your institutional intranet to have access to the Dove Medical Press journals please contact me.
